Detalles de la búsqueda
1.
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
J Infect Dis
; 228(Suppl 7): S660-S670, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171813
2.
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
Nature
; 520(7549): 688-691, 2015 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25853476
3.
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
J Virol
; 92(3)2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29142131
4.
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
J Infect Dis
; 218(suppl_5): S582-S587, 2018 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29939296
5.
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
J Virol
; 91(8)2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28148802
6.
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.
Proc Natl Acad Sci U S A
; 112(9): E992-9, 2015 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25681373
7.
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
J Infect Dis
; 212 Suppl 2: S443-51, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109675
8.
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
PLoS Negl Trop Dis
; 16(5): e0010433, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35622847
9.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Vaccine
; 39(38): 5436-5441, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373117
10.
Immune correlates of postexposure vaccine protection against Marburg virus.
Sci Rep
; 10(1): 3071, 2020 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32080323
11.
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
Lancet Infect Dis
; 20(4): 455-466, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31952923
12.
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
J Clin Invest
; 130(1): 539-551, 2020 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820871
13.
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Mol Ther Oncolytics
; 10: 1-13, 2018 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29998190
14.
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
PLoS One
; 13(9): e0202753, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30235286
15.
Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmids.
DNA Cell Biol
; 26(12): 827-40, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17979522
16.
An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
Viral Immunol
; 30(3): 178-195, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28085634
17.
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.
Sci Transl Med
; 9(419)2017 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29212716
18.
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.
Clin Vaccine Immunol
; 24(11)2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28931520
19.
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
AIDS Res Hum Retroviruses
; 21(7): 629-43, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16060834
20.
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.
PLoS One
; 10(8): e0134287, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26252526